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Abstract
Background:  Transcription factors have distinct functions in regulating immune responses.
During  Escherichia coli pneumonia, deficiency of NF-κB p50 increases gene expression and
neutrophil recruitment, suggesting that p50 normally limits these innate immune responses. p50-
deficient mice were used to determine how p50 regulates responses to a simpler, non-viable
bacterial stimulus in the lungs, E. coli lipopolysaccharide (LPS).
Results: In contrast to previous results with living E. coli, neutrophil accumulation elicited by E. coli
LPS in the lungs was decreased by p50 deficiency, to approximately 30% of wild type levels. Heat-
killed  E. coli induced neutrophil accumulation which was not decreased by p50 deficiency,
demonstrating that bacterial growth and metabolism were not responsible for the different
responses to bacteria and LPS. p50 deficiency increased the LPS-induced expression of κB-
regulated genes essential to neutrophil recruitment, including KC, MIP-2, ICAM-1, and TNF-α
suggesting that p50 normally limited this gene expression and that decreased neutrophil
recruitment did not result from insufficient expression of these genes. Neutrophils were
responsive to the chemokine KC in the peripheral blood of p50-deficient mice with or without LPS-
induced pulmonary inflammation. Interleukin-6 (IL-6), previously demonstrated to decrease LPS-
induced neutrophil recruitment in the lungs, was increased by p50 deficiency, but LPS-induced
neutrophil recruitment was decreased by p50 deficiency even in IL-6 deficient mice.
Conclusion: p50 makes essential contributions to neutrophil accumulation elicited by LPS in the
lungs. This p50-dependent pathway for neutrophil accumulation can be overcome by bacterial
products other than LPS and does not require IL-6.
Background
The innate immune response to bacteria in the lungs
requires the recruitment and activation of neutrophils,
mediated by the coordinated expression of diverse genes
(see [1] for review). In rodents, neutrophils recognize at
least 2 chemokines (KC and macrophage inflammatory
protein-2, MIP-2) that are synthesized de novo in response
to gram-negative bacteria or LPS in the lungs, and each is
independently essential to maximal neutrophil recruit-
ment [2-4]. Neutrophils also recognize the adhesion mol-
ecule intercellular adhesion molecule-1 (ICAM-1). ICAM-
1 is constitutively expressed, but LPS and gram-negative
bacteria in the lungs result in increased expression [5,6]
and ICAM-1 is required for maximal neutrophil emigra-
tion [7,8]. In addition, the early response cytokines TNF-
α and IL-1β are synthesized in response to LPS or gram-
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negative bacteria in the lungs, and receptors for these
cytokines are essential to neutrophil emigration [9].
The coordinated expression of diverse genes may be medi-
ated in part by common transcription factors. All of the
above genes contain κB sites in their 5'-untranslated pro-
moter regions, and mutation of these sites inhibits the
inducible expression of reporter genes driven by these
promoter regions (see reference [10] and references
therein). Thus, NF-κB proteins may mediate the LPS-
induced expression of genes controlling neutrophil emi-
gration in the lungs.
LPS in the lungs induces the nuclear translocation of the
NF-κB proteins RelA (also known as p65) and p50
[11,12]. RelA contains a transactivation domain which
recruits coactivator complexes, increasing gene expression
[13,14]. The genetic deficiency of RelA inhibits the LPS-
induced pulmonary expression of the chemokines KC and
MIP-2 and the adhesion molecule ICAM-1, resulting in
decreased neutrophil emigration [15]. Thus, RelA is essen-
tial to the gene expression mediating neutrophil emigra-
tion induced by LPS in the lungs. p50 is more complex,
capable of either increasing or decreasing gene expression
in vitro [16-24]. During E. coli pneumonia, the deficiency
of p50 increases the expression of multiple κB-regulated
genes, resulting in increased neutrophil recruitment and
excessive inflammatory injury [25].
In the present manuscript, we report that p50 deficiency
had a very different effect on neutrophil recruitment elic-
ited by E. coli LPS in the lungs. In marked contrast to E.
coli, E. coli LPS elicited neutrophil accumulation which
was significantly decreased by p50 deficiency. p50 defi-
ciency did not diminish neutrophil accumulation elicited
by heat-killed E. coli, indicating that p50 dependency
could be overcome by bacterial products other than LPS.
Peripheral blood neutrophils remained responsive to the
chemokine KC in p50-deficient mice, arguing against a
functional desensitization of chemokine receptors. IL-6
was overexpressed in p50-deficient lungs, and IL-6 can
decrease neutrophil recruitment to intrapulmonary LPS
[26,27], but excessive IL-6 was not responsible for the
decreased neutrophil recruitment of p50-deficient mice.
Although the mechanism remains unclear, these studies
demonstrate for the first time that p50 facilitates neu-
trophil accumulation in response to some stimuli in the
lungs, including E. coli LPS.
Results
Effect of p50 deficiency on LPS-induced neutrophil 
recruitment
Neither WT nor p50-deficient mice have neutrophils in
their air spaces in the absence of experimental pulmonary
inflammation [25]. The intratracheal instillation of E. coli
LPS elicited neutrophil emigration in both genotypes, but
there were significantly fewer emigrated neutrophils in the
alveolar air spaces of p50-deficient mice compared to WT
(Figures 1A,1B,1C). There was no difference between gen-
otypes in neutrophils within the alveolar septae of p50-
deficient mice (Figure 1D), and there were significantly
more neutrophils in the peripheral blood of p50-deficient
mice compared to WT during LPS-induced pulmonary
inflammation (Figure 1E). Therefore, the decreased neu-
trophils in alveolar air spaces did not result from inade-
quate delivery of neutrophils to pulmonary capillaries.
These data suggest that p50 deficiency may compromise
transit from the pulmonary capillaries to the alveolar air
spaces.
Effect of p50 deficiency on neutrophil recruitment elicited 
by heat-killed E. coli
The observation that p50 deficiency decreased neutrophil
recruitment elicited by E. coli LPS in the lungs was surpris-
ing in light of previous studies indicating no such effect
(or in fact the opposite effect) of p50 deficiency on neu-
trophil recruitment elicited by E. coli in the lungs [25].
Differing responses to LPS and living bacteria could be
due to bacterial products other than LPS, or to the growth
and metabolism of the bacteria. To determine whether
bacterial products other than LPS were capable of over-
coming p50 dependency in the absence of bacterial
growth and metabolism, WT and p50-deficient mice
received instillations of heat-killed E. coli. Neutrophils
were observed in the alveolar air spaces after the instilla-
tion of heat-killed E. coli, and there were no significant dif-
ferences between genotypes (Figure 2). Therefore, in
contrast to E. coli LPS (Figure 1B), heat-killed E. coli
induced neutrophil recruitment which does not require
p50. These data indicate that other E. coli molecules are
sufficient to bypass or overcome the p50-dependent path-
way of neutrophil recruitment elicited by LPS in the lungs.
Increased LPS-induced gene expression due to p50 
deficiency
p50 could be essential to neutrophil recruitment if it
induces the expression of κB-regulated genes which medi-
ate LPS-induced neutrophil recruitment, such as ICAM-1
[8], KC [2], or MIP-2 [4]. There were no significant differ-
ences in ICAM-1 RNA prior to LPS instillation (Figure 3).
LPS increased ICAM-1 RNA in both WT and p50-deficient
mice (Figure 3), and there was significantly more ICAM-1
in LPS-inflamed p50-deficient lungs compared to WT
(Figure 3). Thus, LPS-induced ICAM-1 expression was
increased by p50 deficiency, arguing against an essential
role for p50 in inducing this gene.
Previous data indicated no detectable KC or MIP-2, meas-
ured at the protein level by ELISA, in bronchoalveolar lav-
age fluids (BALF) from WT or p50-deficient mice withoutBMC Immunology 2004, 5 http://www.biomedcentral.com/1471-2172/5/10
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Effect of p50 deficiency on neutrophil recruitment elicited by LPS in the lungs Figure 1
Effect of p50 deficiency on neutrophil recruitment elicited by LPS in the lungs. E. coli LPS was instilled intratrache-
ally to WT and p50-deficient mice, and lungs and blood were collected after 24 hours. Representative histologic images from 
lungs of WT and p50-deficient mice are shown (A and B, respectively). Emigrated neutrophils (C) in the alveolar air spaces, and 
sequestered neutrophils (D) in the alveolar septae, were quantified using morphometric analyses of histologic sections. Circu-
lating neutrophils (E) were quantified in blood samples collected from the inferior vena cava. Asterisks (*) denote significant dif-
ferences from WT mice.
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experimental inflammation [25]. Thus, p50 deficiency
does not affect basal expression of these chemokines in
the lungs. Both chemokines were detectable in all mice 6
and 24 hours after LPS instillation (Figure 4A,4B). There
were significantly more of these neutrophil chemokines
in BALF from p50-deficient mice compared to WT at the 6
hour time point (Figure 4A,4B). These data suggest that, as
during E. coli pneumonia, p50 serves to limit rather than
augment the expression of these chemokines. Therefore,
insufficient expression of ICAM-1, KC, and MIP-2 was not
responsible for the effect of p50 deficiency on neutrophil
recruitment elicited by LPS in the lungs.
TNF-α and IL-1β contribute to neutrophil recruitment
elicited by E. coli in the lungs [9]. There is little TNF-α
(<10 pg/ml) or IL-1β (<4 pg/ml) in BALF from WT or p50-
deficient mice without experimental inflammation, and
no significant differences between genotypes [25]. These
cytokines were elaborated in response to E. coli LPS (Fig-
ure 4C,4D). The concentrations of TNF-α were elevated in
the BALF from p50-deficient mice compared to WT (Fig-
ure 4C). For IL-1β concentrations in the BALF, there was
no significant effect of p50 deficiency (Figure 4D). Thus,
decreased neutrophil recruitment did not result from
insufficient elaboration of these early response cytokines.
Some cytokines, such as MIP-2 and TNF-α, are expressed
very rapidly in response to LPS in the lungs [28,29].
Therefore, we also examined the concentrations of these
cytokines at an earlier time point, 3 hours after LPS instil-
lation. Both cytokines were detectable in all mice
Effect of p50 deficiency on neutrophil recruitment elicited by  heat-killed E. coli in the lungs Figure 2
Effect of p50 deficiency on neutrophil recruitment 
elicited by heat-killed E. coli in the lungs. E. coli that had 
been killed by autoclaving (as indicated by an inability to grow 
in culture) were instilled intratracheally to WT and p50-defi-
cient mice, and lungs were collected after 24 hours. Emi-
grated neutrophils in the alveolar air spaces were quantified 
using morphometric analyses of histologic sections. There 
were no significant effects of p50 deficiency.
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Effect of p50 deficiency on ICAM-1 expression in the lungs Figure 3
Effect of p50 deficiency on ICAM-1 expression in the 
lungs. cDNA was prepared from RNA in lungs collected 
from WT and p50-deficient mice. ICAM-1 expression was 
measured by semi-quantitative multiplex RT-PCR. The auto-
radiograph (A) shows representative samples, with each lane 
containing amplicons of ICAM-1 message and 18S rRNA 
from cDNA reverse transcribed from lung RNA of an inde-
pendent mouse. The graph (B) depicts ICAM-1 message for 
each sample expressed relative to the densitometric value of 
18S rRNA from the same PCR reaction tube. Bars depict 
mean and SEM from 4–7 mice per group, and asterisk (*) 
denotes significant difference from WT mice.
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Effect of p50 deficiency on cytokine concentrations in the air spaces of the lungs during LPS-induced pulmonary inflammation Figure 4
Effect of p50 deficiency on cytokine concentrations in the air spaces of the lungs during LPS-induced pulmo-
nary inflammation. Bronchoalveolar lavage fluids were collected from WT and p50-deficient mice after E. coli LPS was 
instilled intratracheally. Concentrations of MIP-2 (A), KC (B), TNF-α (C), and IL-1β (D) in the lavage fluids were quantified by 
ELISA. Asterisks (*) denote significant differences from WT mice.
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examined (MIP-2 at concentrations of 367 ± 120 and 194
± 70 pg/ml, and TNF-α at concentrations of 1268 ± 238
and 655 ± 70 pg/ml, in WT and p50-deficient mice,
respectively). Concentrations did not significantly differ
between WT and p50-deficient mice at this time point.
Furthermore, concentrations of these cytokines at 3 hours
failed to reach the values attained by p50-deficient mice at
6 hours, supporting the concept that p50 deficiency
resulted in an overall increase in these cytokines in the air
spaces after LPS exposure.
Capacity of p50-deficient neutrophils to respond to 
chemokine
Neutrophils can be desensitized to chemoattractants by
exposure to excessive concentrations of them [30-32].
During LPS-induced pulmonary inflammation, circulat-
ing neutrophils in p50-deficient mice get exposed to
increased levels of KC in the plasma (Figure 5A). Thus,
p50-deficient neutrophils may get desensitized to the
effects of KC. To determine whether neutrophils in the cir-
culating blood of WT and p50-deficient mice could
respond to this chemokine, neutropenia induced by intra-
venous KC was compared in WT and p50-deficient mice
with and without LPS-induced pulmonary inflammation.
In the absence of pulmonary inflammation, intravenous
KC rapidly induced a near complete neutropenia in both
WT and p50-deficient mice (Figure 5B). At least 93% of
circulating neutrophils were responsive to KC in both
genotypes (Figure 5B). Neutropenia induced by KC did
not significantly differ between genotypes (Figure 5B).
After 6 hours of LPS-induced pulmonary inflammation,
intravenous injection of KC induced a more moderate
neutropenia compared to in the absence of pulmonary
inflammation (Figure 5C). Intravenous KC induced
greater neutropenia in p50-deficient mice than in WT
mice (Figure 5C). Thus, during LPS-induced pulmonary
inflammation, a greater fraction of circulating neutrophils
were responsive to KC in p50-deficient mice compared to
WT mice. These data suggest that the decreased emigration
of p50-deficient neutrophils did not result from an inabil-
ity of blood neutrophils to respond to chemokines.
Effect of p50 deficiency on LPS-induced neutrophil 
recruitment in the absence of IL-6
IL-6 is a κB-regulated factor which decreases LPS-induced
neutrophil recruitment in the lungs [26,27]. In the
absence of experimental inflammation, IL-6 concentra-
tions in BALF of WT and p50-deficient mice are low (<60
pg/ml) and not different between genotypes [25]. IL-6
Effect of p50 deficiency on chemokine responsiveness of blood neutrophils Figure 5
Effect of p50 deficiency on chemokine responsiveness of blood neutrophils. (A) Effect of p50 deficiency on concen-
trations of neutrophil chemokines in the blood. E. coli LPS was instilled intratracheally to WT and p50-deficient mice, blood was 
collected after 6 hours, and the concentrations of MIP-2 and KC were quantified by ELISA. Asterisks (*) denote significant dif-
ferences from WT mice. (B) Effect of p50 deficiency on the ability of blood neutrophils to respond to the chemokine KC. Since 
chemoattractants induce cell stiffening which results in neutropenia, circulating neutrophils (PMN) were counted before and 
after the intravenous injection of recombinant murine KC. Circulating neutrophils were quantified by differential counting of 
blood samples collected from the inferior vena cava. There were no significant effects of p50 deficiency. (C) Effect of p50 defi-
ciency on the ability of blood neutrophils to respond to the chemokine KC during LPS-induced pulmonary inflammation. E. coli 
LPS was instilled intratracheally to WT and p50-deficient mice, and 6 hours later neutrophil responsiveness to recombinant 
murine KC was assessed as described above. Asterisks (*) denote significant differences from WT mice.
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concentrations were elevated in BALF from p50-deficient
mice compared to WT mice during LPS-induced pulmo-
nary inflammation (Figure 6A), suggesting that excessive
IL-6 could be responsible for decreasing neutrophil
recruitment in p50-deficient lungs. To test this hypothesis,
we crossed p50 deficiency into an IL-6-deficient back-
ground and compared neutrophil recruitment in IL-6-
deficient mice and double mutant mice deficient in both
IL-6 and p50. IL-6-deficient mice had many emigrated
neutrophils in their lungs after LPS instillation, and this
neutrophil emigration was decreased by the absence of
p50 (Figure 6B). Similar to in mice with WT IL-6 alleles
(Figure 1A), p50 deficiency reduced emigrated neu-
trophils to approximately 30% of control values in the
absence of IL-6 (Figure 6B). Therefore, the decreased neu-
trophil recruitment due to p50 deficiency during LPS-
induced pulmonary inflammation is independent of any
requirement for IL-6.
Discussion
The deficiency of NF-κB p50 decreased neutrophil recruit-
ment elicited by E. coli LPS in the lungs to 30% of WT lev-
els, indicating that maximal neutrophil recruitment to
this stimulus requires this transcription factor. In contrast,
neutrophil recruitment elicited by either living [25] or
heat-killed E. coli was not decreased in p50-deficient mice
compared to WT, but was 130% or 120% of WT levels,
respectively. Thus, select pathways for neutrophil emigra-
tion depend on NF-κB p50, and these pathways are essen-
tial in response to LPS but not more complex gram-
negative bacterial stimuli.
The LPS preparations used in these studies likely con-
tained both LPS, which activates TLR4, and bacterial lipo-
proteins that signal through TLR2 [33]. Because this semi-
purified LPS preparation induced neutrophil recruitment
that was decreased by p50 deficiency, TLR2 and TLR4
together induce p50-dependent pathways. Based on an
approximation of several ng LPS per million gram-nega-
tive bacteria [34], the instillate of heat-killed E. coli used
here contained 4-5 orders of magnitude less LPS than the
instillate of semi-purified LPS used here. Such an amount
of semi-purified LPS is insufficient to induce neutrophil
recruitment in the lungs (data not shown), indicating that
factors other than LPS or in combination with the low lev-
els of LPS are responsible for inducing neutrophil recruit-
ment to heat-killed E. coli. The present results suggest that
these bacterial products, in contrast to LPS, induce
Role of IL-6 in the decreased neutrophil recruitment of p50-deficient mice during LPS-induced pulmonary inflammation Figure 6
Role of IL-6 in the decreased neutrophil recruitment of p50-deficient mice during LPS-induced pulmonary 
inflammation. (A) Increased IL-6 in the lungs of p50-deficient mice. E. coli LPS was instilled intratracheally to WT and p50-
deficient mice, bronchoalveolar lavage fluids were collected, and IL-6 concentrations were measured by ELISA. Asterisk (*) 
denotes significant difference from WT mice. (B) Effect of p50 deficiency on LPS-induced neutrophil recruitment in the absence 
of IL-6. IL-6-deficient and p50-deficient mice were crossed to generate double mutant mice deficient in both IL-6 and p50. E. 
coli LPS was instilled intratracheally to IL-6-deficient mice and double mutant mice deficient in both IL-6 and p50, and lungs 
were collected after 24 hours. Emigrated neutrophils in the alveolar air spaces were quantified using morphometric analyses of 
histologic sections. Asterisk (*) denotes significant differences from IL-6 deficient mice without mutation in the gene for p50.
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neutrophil recruitment that does not require p50. Candi-
date bacterial products include unmethylated CpG DNA
and n-formyl-methionine peptides; both are likely
included with killed bacteria, and both are capable of
binding host cell receptors and inducing neutrophil
recruitment. In addition, killed bacteria may differ from
semi-purified LPS in forming complexes with soluble host
proteins, such as complement, natural antibody, and sur-
factant proteins, which may alter host signaling and
molecular pathways used for neutrophil emigration.
p50 deficiency increased the expression of κB-regulated
genes induced by LPS in the lungs. Similarly, p50 defi-
ciency increases the expression of κB-regulated genes
induced by living E. coli in the lungs [25]. These data
together suggest that p50 usually functions as a gene
repressor rather than activator during innate immune
responses to bacterial stimuli in the lungs. The data inter-
estingly contrast with the observation that p50 serves as a
gene activator during acquired immune responses to anti-
gen in the lungs, elicited by ovalbumin sensitization and
challenge [35,36]. The molecular mechanisms responsi-
ble for determining whether p50 functions as a repressor
or an activator remain to be determined, but may involve
intracellular signaling pathways which alter the nuclear
proteins associating with p50. For example, p50
homodimers usually recruit a repressor complex contain-
ing histone deacetylase 3 to the KAI1  promoter, but
MEKK1-mediated phosphorylation of a component of
this complex causes it to dissociate from the p50
homodimer and be replaced by a histone acetyl trans-
ferase-containing complex which activates gene transcrip-
tion [37]. p50 may recruit different complexes to different
promoter regions for different purposes during innate and
acquired immune responses in the lungs.
Excessive gene expression due to p50 deficiency may be
responsible for the decreased neutrophil recruitment dur-
ing LPS-induced pulmonary inflammation. Excess levels
of chemokines can desensitize neutrophils in vitro
[30,31], and can inhibit neutrophil recruitment in vivo
[32]. Although KC and MIP-2 concentrations were
increased in the BALF and KC concentrations were
increased in the blood of p50-deficient mice, circulating
neutrophils in p50-deficient mice remained responsive to
the chemokine KC. Desensitization of chemokine recep-
tors therefore seems unlikely to mediate the decreased
neutrophil recruitment. However, excessive chemokine
elaboration could still contribute to the decreased neu-
trophil recruitment. The dose-response curves for neu-
trophil chemoattractants is typically bell-shaped, with in
vitro chemotaxis peaking at an optimum concentration
and then decreasing at higher concentrations [38]. Net
chemokine concentrations in p50-deficient lungs may
have been beyond the optimal concentrations. Further-
more, increasing chemokine concentrations in the blood
may collapse gradients of soluble and/or matrix-bound
chemokine, preventing the directed migration of neu-
trophils [39]. The increased KC concentration in the
blood of p50-deficient mice could have contributed to
such a collapse of chemokine gradients.
Another strong candidate for decreasing neutrophil
recruitment when overexpressed is IL-6. The effect of IL-6
on neutrophil emigration in the lungs is complex and
stimulus-specific [40,41]. During LPS-induced pulmonary
inflammation, adding IL-6 decreases neutrophil emigra-
tion [26] and interrupting IL-6 increases neutrophil emi-
gration [27], suggesting that this cytokine limits LPS-
induced neutrophil recruitment in the lungs. LPS-induced
IL-6 was increased in the BALF of p50-deficient mice com-
pared to WT. Therefore, we hypothesized that excessive IL-
6 expression decreased LPS-induced neutrophil emigra-
tion in p50-deficient mice. We tested this hypothesis by
generating double mutant mice deficient in both p50 and
IL-6, and comparing neutrophil recruitment in double
mutants and mice deficient in IL-6 alone. p50 deficiency
decreased neutrophil recruitment in the absence of IL-6.
These data demonstrate conclusively that p50 facilitates
neutrophil recruitment independent of any requirement
for IL-6.
The precise mechanism by which p50 facilitates neu-
trophil recruitment to E. coli LPS in the lungs remains to
be elucidated. We have measured over 30 genes at the
RNA or protein level (including the present data and data
not shown), and all of them have been either increased or
unchanged by p50 deficiency during LPS-induced
pulmonary inflammation. We have observed no signifi-
cant decreases in gene expression during innate immune
responses in p50-deficient mice. Since p50 clearly limits
the expression of many κB-regulated genes during innate
immune responses to bacterial stimuli in the lungs, we
favor the interpretation that p50 facilitates neutrophil
recruitment in the lungs by decreasing gene expression
which brakes neutrophil recruitment to LPS but not E. coli
in the lungs. However, even within an extremely
simplified system, such as a single cell type (fibroblasts)
treated in vitro with a single stimulus (TNF-α), each NF-κB
subunit has distinct roles that differ among different genes
[42]. Although not yet observed, p50 may increase the
expression of some genes during LPS-induced pulmonary
inflammation. Thus, an alternative mechanistic hypothe-
sis is that NF-κB p50 is essential for the production of
genes yet to be identified which are essential for maximal
neutrophil recruitment to LPS in the lungs.
Conclusions
In response to E. coli or  E. coli LPS, p50 deficiency
increases the expression of multiple κB-regulated genes,BMC Immunology 2004, 5 http://www.biomedcentral.com/1471-2172/5/10
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suggesting that p50 usually limits the expression of these
genes. LPS induces a p50-dependent pathway for neu-
trophil recruitment in the lungs, which can be overcome
or bypassed with bacterial products other than LPS. The
mechanism by which p50 facilitates neutrophil accumula-
tion during LPS-induced pulmonary inflammation
remains to be determined, but we hypothesize that p50
may limit gene expression that interferes with neutrophil
emigration. Deficiency of p50 increases concentrations of
chemokines and of IL-6, each of which can suppress neu-
trophil emigration. However, p50-deficient neutrophils
remain responsive to chemokines, and p50 deficiency
compromises neutrophil recruitment even when IL-6 is
abrogated by gene targeting. Identifying the genes regu-
lated by p50 to facilitate neutrophil recruitment to LPS in
the lungs is an important goal for future studies.
Methods
Mice
Mice with targeted deletion of the Nfkb1 gene [43], defi-
cient in NF-κB p50, and WT mice of similar random
hybrid genetic background (C57BL/6 × 129/Sv) were
maintained under specific pathogen free conditions in a
full barrier facility. In addition, IL-6-deficient (Il6-/-) mice
on a C57BL/6 background (from Jackson Laboratories;
Bar Harbor, ME) were crossed with Nfkb1-/- mice, and
selective breeding resulted in colonies of Nfkb1+/+Il6-/- and
Nfkb1-/-Il6-/-  mice on a similarly random hybrid
background. Mice were 6–10 weeks of age at the time of
experiments. All experimental protocols were approved
by the Harvard Medical Area Standing Committee on
Animals.
Intratracheal instillations
Mice were anesthetized by i.m. injection of ketamine
hydrochloride (100 mg/kg) and acepromazine maleate (5
mg/kg). The trachea was surgically exposed, and 50 µl of
sterile saline containing 100 µg  E. coli LPS serotype
O55:B5 (Sigma; St. Louis, MO) and colloidal carbon at
1%, marking the site of instillation, was instilled through
an angiocatheter inserted via the trachea into the left
bronchus. This dose of LPS was chosen to be consistent
with other studies of molecules mediating neutrophil
emigration in the lungs [12,15,44-46]. In a subset of
experiments, the instillate contained heat-killed E. coli
(strain 19138 from American Type Culture Collection;
Manassas, VA) at a dose equivalent to 106 CFU. After enu-
meration by spectrophotometry and colony-counting, E.
coli were autoclaved and stored in aliquots at -80°C. No
living bacteria could be cultured from these aliquots.
Neutrophil recruitment
Mice were killed by inhalation of a lethal overdose of
halothane anesthesia 24 h after LPS instillation. The
hearts were tied off to maintain pulmonary blood, and
peripheral blood samples were collected from the inferior
vena cava. Lungs were excised and fixed by intratracheal
instillation of 6% glutaraldehyde at a pressure of 23 cm
H2O. Emigrated and sequestered neutrophils were quan-
tified by morphometric analyses of histologic lung sec-
tions, as previously described [9]. Investigators were
blinded to the genotypes of the mice during
morphometric examination. Circulating neutrophils were
quantified in peripheral blood samples. After RBC lysis,
leukocytes were counted using a hemacytometer, and dif-
ferential distributions were assessed in blood smears
stained with LeukoStat (Fisher Scientific; Pittsburgh, PA).
ICAM-1 expression
Pulmonary expression of ICAM-1 was measured by multi-
plex RT-PCR using sets of primers specific for ICAM-1 and
18S rRNA, as previously described [45]. Mice were killed
by overdose of halothane at the indicated times after LPS
instillation, and left lung lobes were snap-frozen and
stored at -80°C. RNA was isolated from lungs using RNe-
asy kits (Qiagen; Valencia, CA), and cDNA was prepared
using Advantage RT-for-PCR (Clontech; Palo Alto, CA).
Preliminary experiments identified the PCR conditions
that produced a linear relationship between input RNA
and signal from amplified product. ICAM-1 RNA was
amplified through 19 cycles of 25 s at 95 C, 35 s at 55 C,
and 50 s at 72 C. PCR reactions contained α[32P]ATP to
label products for autoradiography and densitometry
after separation by electrophoresis. Every PCR tube con-
tained 50 pmol each of the following primers: GGGTC-
CAGGCAGGAGTCTCATCCAGCAGGC plus
GGTGAAGTCTGTCAAACAGGA (for ICAM-1) and
CTTAAAGGAATTGACGGAAG plus
TCCGCAGGTTCACCTACGGA (for 18S rRNA). The
ICAM-1 primers were specific for sequences in exons 6
and 7 that are contained in all full-length and alternatively
spliced forms of murine ICAM-1 that have been described
[45,47,48]. Sequencing of the amplified product demon-
strated 100% homology to the expected ICAM-1
sequence. ICAM-1 expression for each lung sample was
expressed relative to the densitometric value of 18S rRNA
from the same PCR reaction tube.
Cytokine concentrations
Cytokine concentrations were measured in the BALF and
blood plasma collected from WT and p50-deficient mice
at indicated times after LPS instillation. Mice were killed
by lethal overdose of halothane. Blood was collected by
venipuncture of the inferior vena cava. Plasma was sepa-
rated from blood cells by centrifugation. The trachea was
cannulated, and lungs were lavaged 12 times with 0.8–1.0
ml volumes of PBS. The 12 lavageates were pooled, and
cells and debris were removed by centrifugation. Aliquots
of BALF and of plasma were snap-frozen and stored at -BMC Immunology 2004, 5 http://www.biomedcentral.com/1471-2172/5/10
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80°C until analyzed by ELISA (R&D Systems; Minneapo-
lis, MN).
Chemokine responsiveness
The intravascular administration of chemoattractants
causes responsive leukocytes to stiffen and become tran-
siently sequestered in the pulmonary capillaries, resulting
in a rapid removal of responsive cells from the circulation
[49]. This system was used as an in vivo assay for the abil-
ities of neutrophils to respond to chemokines within the
relevant environment (i.e., the blood of that genotype,
with or without LPS-induced pulmonary inflammation).
Mice were anesthetized by i.m. injection of ketamine
hydrochloride (100 mg/kg) and acepromazine maleate (5
mg/kg). The peritoneal cavity was opened to expose the
inferior vena cava, and 100 µl of sterile, pyrogen-free
saline containing recombinant murine KC (0.01 mg/kg
body weight; R&D Systems) was injected into a tail vein.
A 50 µl blood sample was collected from the inferior vena
cava before and both 30 and 120 seconds after KC injec-
tion. Mice were killed by halothane overdose after the last
blood draw. Circulating neutrophils were quantified in
peripheral blood samples, as above.
Statistics
When WT and p50-deficient mice were examined at a sin-
gle time point, data were compared using a t-test for inde-
pendent samples. When WT and p50-deficient mice were
examined at multiple time points, data were compared
using factorial ANOVA and individual groups were com-
pared post hoc using the Tukey Honest Significant Differ-
ence test. Graphs show the mean and SE from 4–10 mice
per group. Groups were considered significantly different
when p < 0.05.
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